183 related articles for article (PubMed ID: 17365940)
1. Relationships between brain natriuretic peptide, troponin I and QT dispersion in asymptomatic dialysis patients.
Taskapan MC; Taskapan H; Ulutas O; Orhan M; Sahin I
Ren Fail; 2007; 29(2):221-5. PubMed ID: 17365940
[TBL] [Abstract][Full Text] [Related]
2. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
[TBL] [Abstract][Full Text] [Related]
3. Influence of intraperitoneal volume on QT dispersion in patients with continuous ambulatory peritoneal dialysis: acute cardiac impact of peritoneal dialysis.
Kocak G; Azak A; Huddam B; Yalcin F; Güven B; Can M; Duranay M
Ren Fail; 2011; 33(6):568-71. PubMed ID: 21631168
[TBL] [Abstract][Full Text] [Related]
4. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
[TBL] [Abstract][Full Text] [Related]
5. Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis.
Nakatani T; Naganuma T; Masuda C; Uchida J; Sugimura T; Sugimura K
Int J Mol Med; 2002 Oct; 10(4):457-61. PubMed ID: 12239593
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between B-type natriuretic peptide plasma level and left ventricular function in patients with chronic kidney disease on different type of treatment].
Rasić S; Hadzovic-Dzuvo A; Rebić D; Dzemidzić J; Bilal F; Mataradzija A
Acta Med Croatica; 2008; 62 Suppl 1():7-11. PubMed ID: 18578326
[TBL] [Abstract][Full Text] [Related]
7. [Risk of arrhythmias in hemodialysis patients vs healthy people].
Milone F; Urso S; Garozzo M; Memeo AM; Volpe G; Battaglia G
G Ital Nefrol; 2004; 21 Suppl 30():S241-6. PubMed ID: 15750993
[TBL] [Abstract][Full Text] [Related]
8. [Value of plasma brain natriuretic peptide detection in cardiac function assessment in hemodialysis patients].
Shao YH; Lai YQ; Lin AZ; Kong YZ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):892-4. PubMed ID: 16027094
[TBL] [Abstract][Full Text] [Related]
9. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure.
Ralli S; Horwich TB; Fonarow GC
Am Heart J; 2005 Dec; 150(6):1220-7. PubMed ID: 16338262
[TBL] [Abstract][Full Text] [Related]
10. Plasma human brain natriuretic peptide in chronic renal failure.
Akiba T; Tachibana K; Togashi K; Hiroe M; Marumo F
Clin Nephrol; 1995 Nov; 44 Suppl 1():S61-4. PubMed ID: 8608666
[TBL] [Abstract][Full Text] [Related]
11. Cardiac findings in asymptomatic chronic hemodialysis patients with persistently elevated cardiac troponin I levels.
Katerinis I; Nguyen QV; Magnin JL; Descombes E
Ren Fail; 2008; 30(4):357-62. PubMed ID: 18569907
[TBL] [Abstract][Full Text] [Related]
12. [Differences in cardiac troponin I and T levels measured in asymptomatic hemodialysis patients with last generation immunoassays].
Deléaval P; Descombes E; Magnin JL; Martin PY; Fellay G
Nephrol Ther; 2006 May; 2(2):75-81. PubMed ID: 16895718
[TBL] [Abstract][Full Text] [Related]
13. The effect of iron stores on corrected QT dispersion in patients undergoing peritoneal dialysis.
Wu VC; Huang JW; Wu MS; Chin CY; Chiang FT; Liu YB; Wu KD
Am J Kidney Dis; 2004 Oct; 44(4):720-8. PubMed ID: 15384024
[TBL] [Abstract][Full Text] [Related]
14. Brain natriuretic peptide and P wave duration in dialysis patients.
Taskapan MC; Senel S; Ulutas O; Aksoy Y; Sahin I; Kosar F; Taskapan H
Int Urol Nephrol; 2007; 39(2):603-8. PubMed ID: 17457688
[TBL] [Abstract][Full Text] [Related]
15. Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients.
Ludka O; Spinar J; Tomandl J; Konecny T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):325-30. PubMed ID: 23154540
[TBL] [Abstract][Full Text] [Related]
16. Changes in QT intervals in patients with end-stage renal disease before and after hemodialysis.
Malhis M; Al-Bitar S; Farhood S; Zaiat KA
Saudi J Kidney Dis Transpl; 2010 May; 21(3):460-5. PubMed ID: 20427869
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin is associated with brain natriuretic peptide and left ventricular hypertrophy in hemodialysis patients with type 2 diabetes mellitus.
Komaba H; Igaki N; Goto S; Yokota K; Takemoto T; Hirosue Y; Goto T
Nephron Clin Pract; 2007; 107(3):c103-8. PubMed ID: 17890872
[TBL] [Abstract][Full Text] [Related]
18. The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease.
Sheen V; Bhalla V; Tulua-Tata A; Bhalla MA; Weiss D; Chiu A; Abdeen O; Mullaney S; Maisel A
Am Heart J; 2007 Feb; 153(2):244.e1-5. PubMed ID: 17239684
[TBL] [Abstract][Full Text] [Related]
19. The relationship between serum concentration of cardiac troponin I in chronic renal failure patients and cardiovascular events.
Vichairuangthum K; Leowattana W; Ong-Ajyooth L; Pokum S
J Med Assoc Thai; 2006 May; 89(5):714-20. PubMed ID: 16756060
[TBL] [Abstract][Full Text] [Related]
20. Risk prediction in chest pain patients by biochemical markers including estimates of renal function.
Eggers KM; Dellborg M; Oldgren J; Swahn E; Venge P; Lindahl B
Int J Cardiol; 2008 Aug; 128(2):207-13. PubMed ID: 17662484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
